CompletedNot Applicable

Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma

China80 participantsStarted 2022-03-01

Plain-language summary

The goal of this non randomized control clinical research study is to compare the cosmetic outcomes and efficiacy of retro-auricular single-site endoscopic thyroid lobectomy and central lymph node dissection against conventional resection.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18-70 years old, no gender restrictions.
✓. Fine-needle aspiration cytology(FNA) confirmed papillary thyroid carcinoma(PTC).
✓. Early stage PTC (stage T1N0M0).
✓. Preoperative ultrasonography showed unilateral glandular lobe malignant tumor and the largest diameter was not more than 2cm, without cervical lymph node metastasis and extensive metastasis.
✓. Patients undergoing thyroid lobectomy and central lymph node dissection.
✓. Patients who have signed an approved Informed Consent.

Exclusion criteria

✕. Patients who do not accept case data collection for various reasons.
✕. The clinical data unfit this study (at the discretion of the investigator).
✕. Patients who have undergone neck surgery or radiotherapy before this trail.
✕. Patients who have uncontrolled hyperthyroidism.

What they're measuring

postoperative cosmetic satisfaction scores

Timeframe: 3 months from surgery

Trial details

NCT IDNCT05263141

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-30

View on ClinicalTrials.gov More Papillary Thyroid Carcinoma trials